1. Kidney transplant recipients’ attitudes toward COVID‐19 vaccination and barriers and enablers to vaccine acceptance
- Author
-
Claire Dendle, Dhakshayini Tharmaraj, Kevan R. Polkinghorne, and William R. Mulley
- Subjects
Adult ,Vaccine safety ,medicine.medical_specialty ,COVID-19 Vaccines ,Coronavirus disease 2019 (COVID-19) ,vaccine intention ,Psychological intervention ,vaccination promotion ,Referral service ,Kidney transplant ,medicine ,Humans ,Vaccines ,Transplantation ,SARS-CoV-2 ,business.industry ,Vaccination ,COVID-19 ,Original Articles ,renal transplantation ,Vaccine efficacy ,Kidney Transplantation ,Transplant Recipients ,SARS‐CoV2 vaccine ,Infectious Diseases ,Attitude ,Renal transplant ,Family medicine ,vaccine hesitancy ,vaccine refusal ,Original Article ,business - Abstract
Objective To identify barriers and enablers to COVID‐19 vaccination in renal transplant recipients who are undecided about vaccination. Methods An online survey was distributed to 876 adult kidney transplant recipients at a tertiary referral service, who had not been vaccinated against COVID‐19. The survey assessed willingness to be vaccinated, attitudes toward COVID‐19 vaccines, and barriers and enablers to proceeding with vaccination. Results The survey response rate was 54% (473/876). Three hundred and forty‐six (73.1%) participants planned to receive vaccination (yes group), 105 (22.2%) were undecided, and 22 (4.7%) refused vaccination. The undecided group were younger but were not different in other demographic characteristics to the yes group. The undecided group were less positive toward (34.29% vs. 91.3%, p, 22.2% of transplant recipients were undecided about having the COVID‐19 vaccine. This group were less positive and more concerned about the vaccine. Concerns about vaccine safety, insufficient vaccine information and concerns about vaccine efficacy were barriers to vaccine uptake whereas information and recommendation to have the vaccine by their transplant specialist/team and transplant clinic consultation were enablers of vaccine uptake. The majority (95.1%) would proceed with vaccination with the right supports.
- Published
- 2021